From the IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria (B.J.H., J.M.P.); and Department of Pediatrics III-Cardiology, Pulmonology, Allergology, Cystic Fibrosis (J.S., U.S., J.-I.S.), Department of Internal Medicine III (Cardiology and Angiology) (B.J.H., T.S., W.D.), and Department of Anesthesia and Intensive Care (C.V.-S.), Medical University of Innsbruck, Innsbruck, Austria.
Circ Res. 2016 Jan 22;118(2):216-21. doi: 10.1161/CIRCRESAHA.115.307017. Epub 2015 Dec 9.
Cardiac remodeling and subsequent heart failure remain critical issues after myocardial infarction despite improved treatment and reperfusion strategies. Recently, cardiac regeneration has been demonstrated in fish and newborn mice after apex resection or cardiac infarctions. Two key issues remain to translate findings in model organisms to future therapies in humans: what is the mechanism and can cardiac regeneration indeed occur in newborn humans?
To assess whether human neonatal hearts can functionally recover after myocardial infarction.
Here, we report the case of a newborn child having a severe myocardial infarction due to coronary artery occlusion. The child developed massive cardiac damage as defined by serum markers for cardiomyocyte cell death, electrocardiograms, echocardiography, and cardiac angiography. Remarkably, within weeks after the initial ischemic insult, we observed functional cardiac recovery, which translated into long-term normal heart function.
These data indicate that, similar to neonatal rodents, newborn humans might have the intrinsic capacity to repair myocardial damage and completely recover cardiac function.
尽管心肌梗死的治疗和再灌注策略有所改善,但心肌梗死后的心脏重构和随后的心力衰竭仍然是一个关键问题。最近,在鱼类和新生小鼠的心脏尖切除或心肌梗死模型中已经证明了心脏再生。要将模型生物中的发现转化为未来人类的治疗方法,仍有两个关键问题需要解决:机制是什么,以及心脏再生是否真的能在新生儿人类中发生?
评估人类新生儿心脏在心肌梗死后是否能够恢复功能。
在这里,我们报告了一例因冠状动脉阻塞导致严重心肌梗死的新生儿。该患儿的血清标志物、心电图、超声心动图和心脏血管造影均显示心肌细胞死亡,提示存在大量心脏损伤。值得注意的是,在初始缺血损伤后的数周内,我们观察到了心脏功能的恢复,这转化为长期的正常心脏功能。
这些数据表明,与新生啮齿动物类似,新生儿人类可能具有内在的修复心肌损伤和完全恢复心脏功能的能力。